Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera

Diabetes and Metabolism

Volumn 35, Issue 1, 2009, Pages 49-56

  Beynat, J ^a   Charles, A ^a   Astruc, K ^b   Metral, P ^b   Chirpaz, L ^a   Bron, A M ^a   Creuzot Garcher, C ^a  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Diabetic retinopathy; Fundus photography; Screening

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CAMERA; CLINICAL FEATURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EYE PHOTOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; RURAL AREA; SCREENING TEST;

ADOLESCENT; ADULT; COLOR; DIABETIC RETINOPATHY; DILATATION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FRANCE; HUMANS; MASS SCREENING; PHOTOGRAPHY; RURAL POPULATION; YOUNG ADULT;

EID: 60349119831     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.07.002     Document Type: Article

References (49)

1. Frank R.N. Diabetic retinopathy. N Engl J Med 350 (2004) 48-58
2. Klein R., Klein B.E., and Moss S.E. Visual impairment in diabetes. Ophthalmology 91 (1984) 1-9
3. Sjolie A.K., Stephenson J., Aldington S., Kohner E., Janka H., Stevens L., et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM complications study. Ophthalmology 104 (1997) 252-260
4. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81 (1976) 383-396
5. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98 (1991) 766-785
6. Ferris F.L. How effective are treatments for diabetic retinopathy?. JAMA 269 (1993) 1290-1291
7. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
8. Type 2 diabetes treatment: French recommendations for good practice AFSSAPS-HAS 2006. Diabetes Metab 2006;32:643-8.
9. Virally M., Blicklé J.F., Girard J., Halimi S., Simon D., and Guillausseau P.J. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab 33 (2007) 231-244
10. Bonaldi C., Romon I., and Fagot-Campagna A. Impact du vieillissement de la population et de l'obésité sur l'évolution de la prévalence du diabète traité : situation en France métropolitaine à l'horizon 2016. Bull Epidemiol Hebd (2006) 69-71. http://www.invs.sante.fr/beh/ Available on www.invs.sante.fr/beh/. [Accessed 17.11.08]
11. Shaw J.E., Zimmet P.Z., McCarty D., and de Courten M. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care 23 (2000) B5-B10
12. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
13. World Health Organization; 2007. (http://www.who.int/topics/diabetes_mellitus). [Accessed 17.11.08].
14. Taylor H.R., and Keeffe J.E. World blindness: a 21st century perspective. Br J Ophthalmol 85 (2001) 261-266
15. Ricordeau P., Weill A., Vallier N., Bourrel R., Fender P., and Allemand H. Epidemiology of diabetes in metropolitan France. Diabetes Metab 26 (2000) 11-24
16. Ricordeau P., Weill A., Vallier N., Bourrel R., Schwartz D., Guilhot J., et al. The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?. Diabetes Metab 29 (2003) 497-504
17. Deb N., Thuret G., Estour B., Massin P., and Gain P. Screening for diabetic retinopathy in France. Diabetes Metab 30 (2004) 140-145
18. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984) 527-532
19. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984) 520-526
20. Échantillon national témoin représentatif des personnes diabétiques (ENTRED); 2002. (http://www.invs.sante.fr/entred).. [Accessed 17.11.08].
21. Bourre T, Corre C. L'ophtalmologie et la filière visuelle en France ; 2006. (http://www.lestroiso.org/doc/rapport2006/snof6020702_rapport.PDF). [Accessed 17.11.08].
22. Berlan Y. Commission démographie médicale ; 2004. (http://www.sante.gouv.fr/htm/actu/berland_demomed/rapport.pdf). [Accessed 17.11.08].
23. Institut national de la statistique et des études économiques ; 2007. (http://www.recensement.insee.fr). [Accessed 17.11.08].
24. Ahmed J., Ward T.P., Bursell S.E., Aiello L.M., Cavallerano J.D., and Vigersky R.A. The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 29 (2006) 2205-2209
25. Massin P., Erginay A., Ben Mehidi A., Vicaut E., Quentel G., Victor Z., et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med 20 (2003) 635-641
26. Boucher M.C., Gresset J.A., Angioi K., and Olivier S. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol 38 (2003) 557-568
27. The Liverpool Declaration on Screening for Diabetic Retinopathy in Europe. Screening for Diabetic Retinopathy in Europe 15 years after the Saint Vincent Declaration; 2005.
28. Massin P, Moty-Monnereau C, David D, Lee-Robin S.H. Évaluation HAS-interpretation des photographies du fond d'oeil, suite à ne retinographie avec ou sans mydriase ; 2007. (http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_retinographie.pdf). [Accessed 17.11.08].
29. Schoenfeld E.R., Greene J.M., Wu S.Y., and Leske M.C. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 108 (2001) 563-571
30. Mukamel D.B., Bresnick G.H., Wang Q., and Dickey C.F. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 6 (1999) 61-72
31. Boucher M.C., Nguyen Q.T., and Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 40 (2005) 734-742
32. Brechner R.J., Cowie C.C., Howie L.J., Herman W.H., Will J.C., and Harris M.I. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 270 (1993) 1714-1718
33. Lee P.P., Feldman Z.W., Ostermann J., Brown D.S., and Sloan F.A. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 110 (2003) 1952-1959
34. Wilson A., Baker R., Thompson J., and Grimshaw G. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. Diabet Med 21 (2004) 271-278
35. Jones D., Dolben J., Owens D.R., Vora J.P., Young S., and Creagh F.M. Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting. Br Med J (Clin Res Ed) 296 (1988) 1029-1030
36. Reda E., Dunn P., Straker C., Worsley D., Gross K., Trapski I., et al. Screening for diabetic retinopathy using the mobile retinal camera: the Waikato experience. NZ Med J 116 (2003) 562
37. Réseau de prévention vasculaire Artois ; 2007. (http://www.prevart.fr).. [Accessed 17.11.08].
38. Choremis J., and Chow D.R. Use of telemedicine in screening for diabetic retinopathy. Can J Ophthalmol 38 (2003) 575-579
39. Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 27 (1987) 230-238
40. Gomez-Ulla F., Fernandez M.I., Gonzalez F., Rey P., Rodriguez M., Rodriguez-Cid M.J., et al. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care 25 (2002) 1384-1389
41. Cavallerano J.D., Aiello L.P., Cavallerano A.A., Katalinic P., Hock K., Kirby R., et al. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol 140 (2005) 667-673
42. Higgs E.R., Harney B.A., Kelleher A., and Reckless J.P. Detection of diabetic retinopathy in the community using a non-mydriatic camera. Diabet Med 8 (1991) 551-555
43. Massin P., Aubert J.P., Erginay A., Bourovitch J.C., Benmehidi A., Audran G., et al. Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab 30 (2004) 451-457
44. Heaven C.J., Cansfield J., and Shaw K.M. The quality of photographs produced by the non-mydriatic fundus camera in a screening programme for diabetic retinopathy: a 1 year prospective study. Eye 7 (1993) 787-790
45. Maberley D., Morris A., Hay D., Chang A., Hall L., and Mandava N. A comparison of digital retinal image quality among photographers with different levels of training using a non-mydriatic fundus camera. Ophthalmic Epidemiol 11 (2004) 191-197
46. American Telemedicine Association. Telehealth Practice Recommendations for Diabetic Retinopathy; 2004. (http://www.atmeda.org/ICOT/diabeticretionpathy.FINAL.pdf).
47. Massin P., Chabouis A., Erginay A., Viens-Bitker C., Lecleire-Collet A., Meas T., et al. OPHDIAT: a telemedical network screening system for diabetic retinopathy in the Ile-de-France. Diabetes Metab 34 (2008) 227-234
48. Erginay A., Chabouis A., Viens-Bitker C., Robert N., Lecleire-Collet A., and Massin P. OPHDIAT: quality-assurance programme plan and performance of the network. Diabetes Metab 34 (2008) 235-242
49. Ramsey S.D., Newton K., Blough D., McCulloch D.K., Sandhu N., and Wagner E.H. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 16 (1999) 285-295